Across the whole pharma sector, there are four or five stocks big one out there which are going to gain market share. So, CDMO is one space within pharma which should do well as we go along. But pharma as a whole space per se has been doing okay and we continue to believe that incrementally also pharma should continue to do well in the coming year also.
What is fuelling M&M’s growth even as the auto sector is slowing down? Anish Shah explains
Mahindra & Mahindra is thriving. The company is witnessing remarkable growth across its businesses. New product launches, especially in the SUV segment, are driving this
November 8, 2024